STROME MARK E 4

What Happened

• Mark E. Strome, a 10% owner of HeartBeam, was granted a derivative award on February 9, 2026 covering 41,380 shares (transaction code A). The Form 4 reports the acquisition at $0.00 (derivative award); no immediate cash purchase or sale occurred. This is an option grant issued under the company’s 2022 Equity Incentive Plan.

Key Details

• Transaction date: February 9, 2026; Report filed: March 23, 2026 (filing appears late relative to the usual 2-business-day Form 4 deadline).
• Award amount: options covering 41,380 shares; reported price $0.00 (derivative).
• Vesting: per footnote, half of the shares vest on March 31, 2026 and the remaining half vest on June 30, 2026; vesting commencement date = January 1, 2026.
• Shares owned after transaction: not specified in the details provided.
• Source: Options issued from the Company’s 2022 Equity Incentive Plan (see footnote F1).

Context

• This was a grant of options (a compensation award), not an open-market buy or sale — there was no immediate cash proceeds or disposition reported. For retail investors, grants can reflect compensation arrangements rather than direct insider buying or selling intent. As a 10% owner, Strome’s holdings are material by ownership class, but this transaction represents an equity award subject to vesting schedules and plan terms.